Literature DB >> 5563961

The importance of the rapid administration of diazoxide in accelerated hypertension.

W J Mroczek, B A Leibel, M Davidov, F A Finnerty.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5563961     DOI: 10.1056/NEJM197109092851104

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  11 in total

Review 1.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

Review 2.  Variability in response to drugs.

Authors:  M D Rawlins
Journal:  Br Med J       Date:  1974-10-12

3.  Effects of fetal exposure to diazoxide in man.

Authors:  R D Milner; S K Chouksey
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

Review 4.  Hypertensive emergencies and urgencies: definition, recognition, and management.

Authors:  J B Reuler; G J Magarian
Journal:  J Gen Intern Med       Date:  1988 Jan-Feb       Impact factor: 5.128

5.  Antihypertensive effect of diazoxide given intravenously in small repeated doses.

Authors:  A McNair; F Andreasen; P E Nielsen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Antihypertensive pharmacology.

Authors:  J G Gerber; C R Freed; A S Nies
Journal:  West J Med       Date:  1980-05

Review 7.  Pharmacokinetics and response to diazoxide in renal failure.

Authors:  R M Pearson
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

8.  Renal function, protein binding and pharmacological response to diazoxide.

Authors:  R M Pearson; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

9.  Intravenous labetalol in hypertensive patients given by fast and slow injection.

Authors:  R M Pearson; C W Havard
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

10.  Malignant hypertension.

Authors:  E Z Rabin
Journal:  Can Med Assoc J       Date:  1978-04-22       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.